Gregory L. Porter, Ph.D., MBA

 
 

Gregory L. Porter, Ph.D., MBA is a strategic marketer for medical device companies, clinical diagnostics and life sciences instrumentation companies. He has experience across the spectrum of marketing including front-end innovation, product development, product commercialization, product launch and downstream product marketing.  He also has experience evaluating potential acquisitions and potential partnerships, evaluating the attractiveness of entering or creating new markets, and evaluating the market for and the financials of innovative product ideas.

Dr. Porter excels at providing initial research on market size by leveraging the scientific and clinical literature and public databases, designing and conducting qualitative and quantitative market research and market modeling to inform business cases, forecasting product demand, and creating financial and market models.  He has experience commercializing a Companion Diagnostic (CDx) in the US, including obtaining CMS’s special  “Innovator” reimbursement.

Greg was Senior Manager, Strategy and Innovation for the corporate level Strategy and Innovation group at BD.  He also has held roles at transnational life sciences and diagnostics companies as a global product marketing manager (Tecan AG and LGC Genomics, now BioSearch Technologies), as a regional market manager with downstream marketing responsibilities (bioMérieux, including microbiology and molecular diagnostics, and Tecan).  Greg also has led teams as a project manager, led go-to-market and exhibition teams, prospected for new strategic accounts as an Executive Director of Business Development, and provided management consulting services as the principal in his own consulting company.

Greg holds a BS in Chemical Engineering from Purdue University, a Ph.D. in Biochemstry from the University of Illinois at Urbana-Champaign, and an MBA from the Fuqua School of Business at Duke University.  He did post-doctoral work at NIEHS Laboratory of Molecular Genetics (IRTA Fellow) and at the University of North Carolina Department of Biochemistry and Biophysics as an NIH National Research Service Award Fellow.  Originally from Indianapolis, Greg has resided in the Research Triangle Area for over 25 years. 

Colleen Lozano